What is Resmed Inc. Quarterly Revenue?

Resmed Inc. Quarterly Revenue ResMed Jun-2026 Quarterly Revenue is $1,464 Million which is growth of 8.6% YoY.

What is Resmed Inc. Quarterly Net Profit?

Resmed Inc. Quarterly Net Profit ResMed Jun-2026 Quarterly Net Profit is $383 Million which is growth of 1.0% YoY.

What is Resmed Inc. Annual Revenue?

Resmed Inc. Annual Revenue ResMed Jun-2026 Annual Revenue is $5,653 Million which is growth of 9.9% YoY.

What is Resmed Inc. Annual Net Profit?

Resmed Inc. Annual Net Profit ResMed Jun-2026 Annual Net Profit is $1,523 Million which is growth of 8.8% YoY.

What is Resmed Inc. Total Shareholders Fund?

Resmed Inc. Total Shareholders Fund ResMed Jun-2026 Total Shareholders Fund is $6,585 Million which is growth of 10.3% YoY.

What is Resmed Inc. Total Assets?

Resmed Inc. Total Assets ResMed Jun-2026 Total Assets is $8,966 Million which is growth of 9.7% YoY.

What is Resmed Inc. Book Value Per Share?

Resmed Inc. Book Value Per Share ResMed Book Value Per Share is $46 which is growth of 12.0% YoY.

What is Resmed Inc. ROE?

Resmed Inc. ROE ResMed ROE is 24% which is growth of 1.6% YoY.

What is Resmed Inc. Cash From Operating Activity?

Resmed Inc. Cash From Operating Activity ResMed Jun-2026 Cash From Operating Activity is $1,806 Million which is growth of 3.1% YoY.

What is Resmed Inc. Net Cash Flow?

Resmed Inc. Net Cash Flow ResMed Jun-2026 Net Cash Flow is $254 Million which is growth of -73.2% YoY.

Resmed Inc.

XNYS: RMD

Turnaround Potential

Download real time

4.55(1.98%)

30.15% Gain from 52W Low

1.0M

XNYS Volume

XNYS 12 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

ResMed quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for ResMed share price target, revenues, EPS, net income and more

ResMed quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue ResMed Jun-2026 Quarterly Revenue is $1,464 Million which is growth of 8.6% YoY.
POSITIVE
Quarterly Net Profit ResMed Jun-2026 Quarterly Net Profit is $383 Million which is growth of 1.0% YoY.

Resmed Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	1,463.7	1,431.4	1,422.8	1,335.6	1,348	1,291.7	1,282.1	1,224.5	1,223.2	1,197	1,162.8	1,102.3	1,122.1
CostOfRevenue_Q Cost Of Rev.	602.4	540.4	544.1	514.8	527.9	525.3	530.8	507.3	507.7	504.2	515.9	502.3	504.7
GrossProfit_Q Gross Profit	861.2	891	878.7	820.8	820.1	766.4	751.3	717.2	715.5	692.8	646.9	600.1	617.4
OEXPNS_Q Operating Exp. ⌄	412.5	391.2	381.1	358.5	363.5	340.1	334	329.9	334.3	318.2	307.6	311.1	331.2
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	296.3	285.7	278.4	259.2	265.1	245.3	241.6	239	242.2	229.9	222.2	222.9	240.7
ResearchAndDevlopmentExpenses_Q RnD Exp.	105.7	94.3	91	87.3	86.4	83.9	81.4	79.5	80.9	77.1	73.9	75.7	78.1
OP_Q Operating Profit	448.7	499.8	497.6	462.4	456.6	426.3	417.2	387.3	381.2	374.6	339.3	289	286.2
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	20.9	12.3	8	8.8	5.8	0.8	-0.8	-1.7	-5.9	-11	-13.8	-15	-14.9
Others_Q Other Interest Earned	-	-	-	-	-	-	-	-	-	-	-	-	-
IntExpNonOperating_Q Interest Exp. Non Operating	-	-	-	-	-	-	-	-	-	-	-	-	-
PBT_Q Profit Before Tax	474.2	502.3	496.2	446.8	458.1	417.7	418.3	383.5	357.7	375.4	259.5	272.2	276.8
TAX_Q Tax	90.7	103.6	103.6	98.3	78.4	52.7	73.7	72.1	65.5	74.9	50.7	52.8	47.1
NICommonStockholders_Q Net Income Common Stockholders ⌄	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
NP_Q Net Profit	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
EPS_Q Basic EPS	2.7	2.7	2.7	2.4	2.6	2.5	2.4	2.1	2	2	1.4	1.5	1.6
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	3	2.9	2.8	2.6	2.6	2.4	2.4	2.2	2.1	2.1	1.9	1.6	1.6
SHARE_Q Number Of Shares End	144.7	145.3	145.8	146.2	146.5	146.7	146.8	146.9	146.9	147	147.1	147.1	147
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
NormalizedIncome_Q Normalized Income	428.3	417.2	411.5	374.9	374.6	348.5	358.3	325.4	306.3	314.4	277.4	241.2	235.5
InterestIncome_Q Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-
INT_Q Interest	-	-	-	-	-	-	-	-	-	-	-	-	-
NetInterestIncome_Q Net Interest Income	20.9	12.3	8	8.8	5.8	0.8	-0.8	-1.7	-5.9	-11	-13.8	-15	-14.9
EBIT_Q EBIT	453.3	490	488.2	438	452.3	416.9	419.1	385.2	363.7	386.5	273.3	287.2	291.8
EBITDA_Q EBITDA	508.4	559.1	550.5	495.7	526.6	468.8	475	438.9	418.4	441.1	326.6	340.6	346.9
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	557.8	482.6	493.5	469.1	465.6	484.3	486	465	464.2	460.8	474.1	461.3	461.8
ReconciledDepreciation_Q Reconciled Depr.	55.1	69	62.3	57.7	74.3	51.9	55.9	53.7	54.8	54.6	53.4	53.4	55.2
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	383.4	398.7	392.6	348.5	379.7	365	344.6	311.4	292.2	300.5	208.8	219.4	229.7
NormalizedEBITDA_Q Normalized EBITDA	503.8	568.8	565.9	535.8	532.9	478.2	473.1	441	362.4	429.2	456.9	342.4	322.3

*All financials are in USD Million and price data in USD

Add metric to table

Search...

ResMed competitor comparison and performance snapshot within industry

ResMed annual results: revenue, profit, P&L, and margins as of Jun 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue ResMed Jun-2026 Annual Revenue is $5,653 Million which is growth of 9.9% YoY.
POSITIVE
Annual Net Profit ResMed Jun-2026 Annual Net Profit is $1,523 Million which is growth of 8.8% YoY.

Resmed Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Jun '26	Jun '25	Jun '24	Jun '23	Jun '22	Jun '21	Jun '20	Jun '19	Jun '18	Jun '17	Jun '16
SR_A Total Rev. Ann. ⌄	10.2%	12.1%		5,653.4	5,146.3	4,685.3	4,223	3,578.1	3,196.8	2,957	2,606.6	2,340.2	2,066.7	1,838.7
TotalOperatingRevenues_A Operating Rev. Ann.	10.2%	12.1%	5,653.4	5,653.4	5,146.3	4,685.3	4,223	3,578.1	3,196.8	2,957	2,606.6	2,340.2	2,066.7	1,838.7
CostOfRevenue_A Cost Of Rev. Ann.	5.6%	10.2%	2,201.7	2,201.7	2,091.4	2,030	1,867.3	1,553.8	1,357.7	1,239.2	1,070	978	865	772.2
GrossProfit_A Gross Profit Ann.	13.6%	13.4%	3,451.7	3,451.7	3,055	2,655.3	2,355.7	2,024.3	1,839.1	1,717.8	1,536.6	1,362.2	1,201.7	1,066.5
OEXPNS_A Operating Exp. Ann.	8.6%	10.7%	1,543.3	1,543.3	1,367.6	1,271.2	1,203.7	1,024	926.8	908.7	900.6	801.9	745	630.6
OP_A Operating Profit Ann.	18.3%	15.9%	1,908.5	1,908.5	1,687.4	1,384.1	1,152	1,000.3	912.4	809.1	636	560.3	456.7	435.9
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	49.9	49.9	4.1	-45.7	-47.4	-22.3	-23.6	-39.4	-33.9	-12	-11.2	5.7
Others_A Other Interest Earned Ann.	-	-		-	-	-	-	-	0.4	1	2.3	16.4	17.1	16.9
IntExpNonOperating_A Interest Exp. Non Operating Ann.	-	-		-	-	45.7	-	-	24	40.4	36.2	28.4	28.2	11.2
OtherExpenses_A Other Exp. Ann.	-	-		-39	-13.9	-73.6	-3	-17.5	-5.1	-36.6	-83.3	-27	-26.8	-2
PBT_A PBT Ann.	20.3%	16.8%	1,919.4	1,919.4	1,677.6	1,264.8	1,101.7	960.5	883.7	733.1	518.9	521.3	418.7	439.6
TAX_A Tax Ann.	24.7%	-0.6%	396.1	396.1	276.8	243.9	204.1	181.1	409.2	111.4	114.3	205.7	76.5	87.2
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
NP_A Net Profit Ann.	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
EPS_A EPS Ann.	19.8%	26%		10.5	9.6	6.9	6.1	5.3	3.3	4.3	2.8	2.2	2.4	2.5
DilutedEPS_A Diluted EPS Ann.	19.5%	26.6%		10.4	9.5	6.9	6.1	5.3	3.2	4.3	2.8	2.2	2.4	2.5
SHARE_Q Number Of Shares End	-0.5%	-0.1%		144.7	146.5	146.9	147	146.4	145.6	145	143.7	143	141.6	140.6
TotalExpenses_A Total Exp. Ann.	6.8%	10.4%		3,745	3,458.9	3,301.2	3,071	2,577.8	2,284.5	2,148	1,970.6	1,779.9	1,610	1,402.9
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
NormalizedIncome_A Normalized Income Ann.	19.8%	15.9%	1,631.8	1,631.9	1,406.8	1,139.3	949.8	850.8	780.6	692.8	526.4	507.8	401.3	398
InterestIncome_A Interest Income Ann.	-	-		-	-	-	-	-	0.4	1	2.3	16.4	17.1	16.9
INT_A Interest Ann.	-	-		-	-	45.7	-	-	24	40.4	36.2	28.4	28.2	11.2
EBITDA_A EBITDA Ann.	16.2%	14%	2,113.7	2,113.7	1,909.3	1,526.7	1,346.6	1,176.6	1,098.8	953.8	703.5	653.3	542.1	520.8
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	5.4%	10.8%	2,003	2,003	1,900.8	1,860.3	1,711.8	1,391.1	1,197.3	1,088	994.1	904.5	799.4	709.3
ReconciledDepreciation_A Reconciled Depr. Ann.	7.3%	5%	244.2	244.2	235.8	216.2	197.6	193.8	191.5	181.4	150.8	120	112.2	86.9
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	19.3%	26.3%	1,523.3	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
NormalizedEBITDA_A Normalized EBITDA Ann.	17.5%	14.7%	2,174.4	2,174.4	1,925.2	1,590.9	1,339.5	1,206.3	1,094.1	967.4	775.8	701.2	586.6	541.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

9.9%

2Y CAGR

9.8%

3Y CAGR

10.2%

5Y CAGR

12.1%

7Y CAGR

11.7%

10Y CAGR

11.9%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

8.8%

2Y CAGR

22.1%

3Y CAGR

19.3%

5Y CAGR

26.3%

7Y CAGR

20.9%

10Y CAGR

15.8%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

12.8%

2Y CAGR

10.2%

3Y CAGR

8.6%

5Y CAGR

10.7%

7Y CAGR

10Y CAGR

9.4%

Operating Expenses Annual Cr growth is higher than historical averages.

ResMed balance sheet as of Jun 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund ResMed Jun-2026 Total Shareholders Fund is $6,585 Million which is growth of 10.3% YoY.
POSITIVE
Total Assets ResMed Jun-2026 Total Assets is $8,966 Million which is growth of 9.7% YoY.

Resmed Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Jun '26	Jun '25	Jun '24	Jun '23	Jun '22	Jun '21	Jun '20	Jun '19	Jun '18	Jun '17	Jun '16
TA_A Total Assets Ann. ⌄	9.9%	13.7%	8,966	8,174.4	6,872.4	6,751.7	5,095.9	4,728.1	4,587.4	4,107.7	3,063.9	3,468.5	3,258.9
CA_A Total Current Assets Ann.	22.2%	22.4%	4,324.7	3,505.6	2,357.7	2,367.8	1,931.5	1,574.8	1,523.5	1,145.4	1,065.7	1,644	1,419.7
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	86.1%	37.8%	1,469.2	1,209.5	238.4	227.9	273.7	295.3	463.2	147.1	188.7	821.9	731.4
Receivables_A Change In Account Receivables Ann.	15.5%	12%	1,085	990.7	837.3	704.9	576	614.3	474.6	528.5	483.7	450.5	382.1
Inventories_A Inventories Ann.	-1.8%	15.7%	945.8	927.7	822.3	998	743.9	457	416.9	349.6	268.7	268.3	224.5
OtherCurrentAssets_A Other Current Assets Ann.	1%	6.4%	185.4	164.5	180	179.9	337.9	135.7	168.7	120.1	124.6	103.2	81.7
TotalNonCurrentAssets_A Total Non Current Assets Ann.	1.9%	8%	4,641.2	4,668.8	4,514.7	4,383.9	3,164.4	3,153.4	3,063.9	2,962.3	1,998.2	1,824.5	1,839.2
NetPPE_A Net PPE Ann.	3.4%	4.4%	735	718.3	699.2	665.8	630.5	592.1	535.7	387.5	386.6	394.2	384.3
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-6.5%	5.9%	214.7	185.8	284	262.5	171.8	160.9	148.7	151	273.7	42.1	40.4
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-3.2%	5.3%	2,380.6	2,206.5	2,008.4	2,621.8	1,735.1	1,842.5	2,090.4	2,035.5	1,004.9	1,508.2	1,564.1
CL_A Total Current Liabilities Ann.	22.5%	8.9%	1,395.1	1,019.1	910.7	758.5	689.3	911.8	602.8	556	511.3	360.1	638.6
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	15.2%	2.9%	885.3	810	718.3	579.1	548.9	766.6	470.5	455.1	436.6	307.8	288.3
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	108.7%	52%	289.1	40.4	35.2	31.8	31.8	35.6	33.3	12	11.5	-	300
CurrentDeferredLiabilities_Q Current Deferred Liabilities	5.7%	8.2%	162.9	166	152.6	138.1	108.7	109.6	98.6	88.7	60.8	51.9	50
OtherCurrentLiabilities_A Other Current Liabilities Ann.	81.9%	-	57.8	2.7	4.7	9.6	-	-	0.4	0.2	2.4	0.5	0.2
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	-19.1%	1.2%	985.5	1,187.4	1,097.7	1,863.3	1,045.8	930.7	1,487.6	1,479.5	493.7	1,148.1	925.6
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-29.7%	-6.7%	536.8	811.4	838.8	1,548.1	885.8	758.1	1,266	1,258.9	270	1,078.6	875
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-			37.2	48.9	62.9	112.9	126.1	138.1	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	16.8%	17.9%	6,585.4	5,967.9	4,864	4,129.9	3,360.8	2,885.7	2,497	2,072.2	2,059	1,960.3	1,694.8
EQCAP_A Equity Share Capital Ann.	16.8%	17.9%	6,585.4	5,967.9	4,864	4,129.9	3,360.8	2,885.7	2,497	2,072.2	2,059	1,960.3	1,694.8
CapitalStock_A Capital Stock Ann.	10.1%	5.9%	0.8	0.8	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6
RetainedEarnings_A Retained Earnings Ann.	19.5%	18.7%	7,255.1	6,081.5	4,991.7	4,253	3,613.7	3,079.6	2,833	2,436.4	2,432.3	2,316.2	2,160.3
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-82.5	-74.7	-251.5	-272.5	-312.8	-193.5	-284	-253	-224.3	-189.1	-222.7
TotalCapitalization_A Total Capitalization Ann.	7.9%	14.6%	6,984.8	6,626.3	5,561.4	5,561.1	4,126.1	3,529	3,661.2	3,331.1	2,329	3,038.9	2,569.8
TangibleAssets_A Tangible Assets Ann.	58.6%	41.6%	3,223.1	2,456.3	1,536.1	807.3	1,078.4	565.2	158.5	-306.2	774.9	633.6	335.8
WC_A Working Capital Ann.	22.1%	34.6%	2,929.6	2,486.5	1,447.1	1,609.3	1,242.2	663	920.7	589.4	554.5	1,283.9	781.2
InvestedCapital_A Invested Capital Ann.	9.2%	15.4%	7,244.8	6,636.2	5,571.3	5,571	4,136	3,541	3,673.2	3,343.1	2,340.4	3,038.9	2,869.8
TangibleBookValue_A Tangible Book Value Ann.	58.6%	41.6%	3,223.1	2,456.3	1,536.1	807.3	1,078.4	565.2	158.5	-306.2	774.9	633.6	335.8
Borrowings_A Borrowings Ann.	-19.4%	0.8%	825.9	851.8	873.9	1,579.9	917.6	793.7	1,299.3	1,270.9	281.5	1,078.6	1,175
NetDebt_A Net Debt Ann.	-	-	-	-	468.9	1,213.2	501.5	360.1	713	1,123.7	92.8	256.7	443.6
ShareIssued_A Share Issued Ann.	-8.6%	-5.1%	144.2	190.3	189.6	188.9	188.3	187.5	186.7	185.5	184.3	183.3	181.8
SHARE_Q Number Of Shares End	-0.5%	-0.1%	144.7	146.5	146.9	147	146.4	145.6	145	143.7	143	141.6	140.6

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

9.7%

2Y CAGR

14.2%

3Y CAGR

9.9%

5Y CAGR

13.7%

7Y CAGR

11.8%

10Y CAGR

10.7%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

36.9%

2Y CAGR

23.8%

3Y CAGR

22.5%

5Y CAGR

8.9%

7Y CAGR

14%

10Y CAGR

8.1%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

10.3%

2Y CAGR

16.4%

3Y CAGR

16.8%

5Y CAGR

17.9%

7Y CAGR

18%

10Y CAGR

14.5%

Total ShareHolders Funds Annual growth is lower than historical averages.

ResMed ROE, ROCE, book value, and debt-to-equity ratio as of Jun 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share ResMed Book Value Per Share is $46 which is growth of 12.0% YoY.
POSITIVE
ROE ResMed ROE is 24% which is growth of 1.6% YoY.

Resmed Inc., Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Jun '26	Jun '25	Jun '24	Jun '23	Jun '22	Jun '21	Jun '20	Jun '19	Jun '18	Jun '17	Jun '16
ROA_A RoA Ann. %	5.5%	11.8%	17.77%	18.62%	14.99%	15.15%	15.87%	10.19%	14.30%	11.28%	9.66%	10.18%	12.95%
ROE_A ROE Ann. %	0.4%	6.6%	24.27%	25.86%	22.70%	23.96%	24.96%	17.63%	27.21%	19.59%	15.70%	18.73%	21.47%
ROIC_Q ROIC %	9.1%	-1.1%	5.2	5.8	5.1	4	4.7	5.5	4.9	2.3	4.3	3.4	3.5
OPMPCT_A OPM Ann. %	7.4%	3.4%	33.76%	32.79%	29.54%	27.28%	27.96%	28.54%	27.36%	24.40%	23.94%	22.10%	23.70%
NBTO_A Inventory Turnover Ratio Ann.	4.6%	-5%	2.4	2.4	2.2	2.1	2.6	3.1	3.2	3.5	3.6	3.5	3.3
ASETTO_A Asset Turnover Ann. %	0%	0%	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.6	0.7
WCTO_A Working Capital Turnover Ann.	-9.9%	-16.9%	1.9	2.1	3.2	2.6	2.9	4.8	3.2	4.4	4.2	1.6	2.4
QuickRatio_A Quick Ratio Ann.	14.5%	12.5%	1.8	2.2	1.2	1.2	1.2	1	1.6	1.2	1.3	3.5	1.7
CRATIO_A Current Ratio Ann.	0%	12.8%	3.1	3.4	2.6	3.1	2.8	1.7	2.5	2.1	2.1	4.6	2.2
IC_A Interest Coverage Ratio Ann.	-	-	-	-	28.7	-	-	37.8	19.2	15.4	19.4	15.8	40.2
LTDE_A LT Debt To Equity Ann.	-37%	-19.7%	0.1	0.1	0.2	0.4	0.3	0.3	0.5	0.6	0.1	0.6	0.5

*All financials are in USD Million and price data in USD

Add metric to table

Search...

ROE Ann. %

1Y CHG

-6.1%

2Y CAGR

3.4%

3Y CAGR

0.4%

5Y CAGR

6.6%

7Y CAGR

3.1%

10Y CAGR

1.2%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-4.6%

2Y CAGR

8.9%

3Y CAGR

5.5%

5Y CAGR

11.8%

7Y CAGR

6.7%

10Y CAGR

3.2%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-8.8%

2Y CAGR

9.2%

5Y CAGR

12.8%

7Y CAGR

5.7%

10Y CAGR

3.5%

Current Ratio Annual is falling faster than historical averages.

ResMed cash flow: net, operating, investing, and financing flows as of Jun 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity ResMed Jun-2026 Cash From Operating Activity is $1,806 Million which is growth of 3.1% YoY.
NEGATIVE
Net Cash Flow ResMed Jun-2026 Net Cash Flow is $254 Million which is growth of -73.2% YoY.

Resmed Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Jun '26	Jun '25	Jun '24	Jun '23	Jun '22	Jun '21	Jun '20	Jun '19	Jun '18	Jun '17	Jun '16
CFO_A Cash from Operating Act. Ann. ⌄	37.6%	19.6%	1,805.8	1,751.6	1,401.3	693.3	351.2	736.7	802.3	459.1	505	414.1	547.9
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	19.3%	26.3%	1,523.3	1,400.7	1,021	897.6	779.4	474.5	621.7	404.6	315.6	342.3	352.4
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	7.3%	5%	244.2	235.8	216.2	197.6	193.8	191.5	181.4	150.8	120	112.2	86.9
DepreciationAndAmortization_A Depreciation And Amortization Ann.	7.3%	5%	244.2	235.8	216.2	197.6	193.8	191.5	181.4	150.8	120	112.2	86.9
DeferredTax_A Deferred Tax Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
EmployeesStockOptions_A ESOPs Ann.	13.7%	10.3%	104.4	91.7	80.2	71.1	65.3	63.9	57.6	52.1	48.4	45.9	46.4
OtherNonCashItems_A Other Non Cash Items Ann.	-	-	-	-	33.2	-11.1	-	8.7	-0	-0.3	0.4	1.6	-3
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-74.2	16.7	44.8	-462.1	-708.1	1.4	-97.9	-177.1	9.1	-89.9	61.7
ChangeInReceivables_A Change In Receivables Ann.	-	-	-96.8	-76.7	-134.3	-106.5	19.4	-129.2	54.4	-18	-32.4	-63.6	-27.3
ChangeInInventory_A Change In Inventory Ann.	-	-	-9.9	-80.2	172.2	-248.8	-311.7	-22	-69.9	-84.2	1.5	-41.6	30.5
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	76.7%	-3.9%	172.7	91	122.1	31.3	-247.6	210.7	-23.4	-27.3	200.7	34.6	46.4
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-545.2	-200	-269.8	-1,159.8	-229.9	-158.5	-179.9	-1,075.7	-101.8	-81.9	-1,125.8
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-156.3	-89.9	-99.5	-119.7	-134.8	-102.7	-95.3	-68.7	-62.6	-62.2	-58.5
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-156.3	-89.9	-99.5	-119.7	-134.8	-102.7	-95.3	-68.7	-62.6	-62.2	-58.5
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-350.7	-139.3	-133.5	-1,012.8	-42.8	-39.1	-27.9	-951.4	-0.9	-7.3	-1,041.9
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-350.7	-139.3	-133.5	-1,012.8	-42.8	-39.1	-27.9	-951.4	-0.9	-7.3	-1,041.9
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-28.5	-6.4	-22.5	-32.2	-37.9	-21.8	-46	-47	-29.5	-6.5	-16.5
SaleOfInvestment_A Sale Of Investment Ann.	-16.3%	-10.2%	11.2	46.3	1	19.1	6.8	19.2	-	-		3.3	0.5
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-1,007	-606.3	-1,119.3	422.9	-128.4	-764.6	-317.3	580.6	-1,026.7	-262.9	612.6
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-10	-40	-730	665	122	-522	-94	807.5	-796.2	-95	856.3
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-10	-40	-730	665	122	-522	-94	807.5	-796.2	-95	856.3
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-625.5	-225.6	-96.9	49.1	47.4	37.8	48.2	13.9	-30.5	30.2	-74.4
CommonStockIssuance_A Common Stock Issuance Ann.	14.9%	14.5%	74.5	74.4	53.1	49.1	47.4	37.8	48.2	36.7	23.3	30.2	27.7
CommonStockPayments_A Common Stock Payments Ann.	-	-	-700	-300	-150	-	-			-22.8	-53.8		-102.1
dividend_1Y_actual Dividend 1year	10.1%	8.4%	2.4	2.1	1.9	1.8	1.7	1.6	1.6	1.5	1.4	1.3	1.2
DividendPerShare_A Dividend Per Share Ann.	10.1%	8.4%	2.4	2.1	1.9	1.8	1.7	1.6	1.6	1.5	1.4	1.3	1.2
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-21.8	-29.8	-10.1	-33	-52.4	-53.7	-46.4	-29	-0.5	-11.7	-1.2
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	86.1%	37.8%	1,469.2	1,209.5	238.4	227.9	273.7	295.3	463.2	147.1	188.7	821.9	731.4
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	253.6	945.3	12.2	-43.7	-7.1	-186.4	305.1	-36	-623.5	69.3	34.8
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	64.1%	21.2%	1,209.5	238.4	227.9	273.7	295.3	463.2	147.1	188.7	821.9	731.4	717.3
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	-	-	-	214	278.4	216.9	478.1	221.4	180.4	242.9	170.7	92.9	69
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-	-	-	28.4	45.7	47.4	22.3	24	40.4	36.2	28.4	28.2	11.2
CapitalExpenditure_A Capex Ann.	-	-	-177.2	-100.6	-114.9	-134	-156	-116.8	-105.9	-77.3	-71.5	-71.5	-67.8
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	14.9%	14.5%	74.5	74.4	53.1	49.1	47.4	37.8	48.2	36.7	23.3	30.2	27.7
IssuanceOfDebt_A Issuance Of Debt Ann.	-	-			105	1,070	288	90	1,190	1,519.2	350	450	1,140
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-10	-40	-835	-405	-166	-612	-1,284	-711.8	-1,146.2	-545	-283.7
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-700	-300	-150	-	-			-22.8	-53.8		-102.1
FreeCashFlow_A Free Cash Flow Ann.	42.8%	21.3%	1,628.7	1,651	1,286.4	559.3	195.1	619.9	696.3	381.7	433.6	342.6	480.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

3.1%

2Y CAGR

13.5%

3Y CAGR

37.6%

5Y CAGR

19.6%

7Y CAGR

21.6%

10Y CAGR

12.7%

Cash from Operating Activity Annual growth is lower than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

30.15% Gain from 52W Low

ResMed quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

ResMed - Forecaster

Forecaster Analyst Estimates for ResMed share price target, revenues, EPS, net income and more

ResMed - Earnings Report - Quarterly Results

ResMed quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue ResMed Jun-2026 Quarterly Revenue is $1,464 Million which is growth of 8.6% YoY.

Quarterly Net Profit ResMed Jun-2026 Quarterly Net Profit is $383 Million which is growth of 1.0% YoY.

ResMed - Competitors/Peers

ResMed competitor comparison and performance snapshot within industry

ResMed - Earnings Report - Annual Results

ResMed annual results: revenue, profit, P&L, and margins as of Jun 2026 – 11 year history

Annual Revenue ResMed Jun-2026 Annual Revenue is $5,653 Million which is growth of 9.9% YoY.

Annual Net Profit ResMed Jun-2026 Annual Net Profit is $1,523 Million which is growth of 8.8% YoY.

ResMed - Balance Sheet

ResMed balance sheet as of Jun 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund ResMed Jun-2026 Total Shareholders Fund is $6,585 Million which is growth of 10.3% YoY.

Total Assets ResMed Jun-2026 Total Assets is $8,966 Million which is growth of 9.7% YoY.

ResMed - Ratios

ResMed ROE, ROCE, book value, and debt-to-equity ratio as of Jun 2026 – 11 year history

Book Value Per Share ResMed Book Value Per Share is $46 which is growth of 12.0% YoY.

ROE ResMed ROE is 24% which is growth of 1.6% YoY.

ResMed - Cash Flow

ResMed cash flow: net, operating, investing, and financing flows as of Jun 2026 – 11 year history

Cash From Operating Activity ResMed Jun-2026 Cash From Operating Activity is $1,806 Million which is growth of 3.1% YoY.

Net Cash Flow ResMed Jun-2026 Net Cash Flow is $254 Million which is growth of -73.2% YoY.